<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2023-4-188-200</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-5435</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW AND LECTURES</subject></subj-group></article-categories><title-group><article-title>Качество жизни и психические расстройства в постковидном периоде (систематический обзор)</article-title><trans-title-group xml:lang="en"><trans-title>Quality of life and mental disorders in the post-COVID period (systematic review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-4723-1494</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семакин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Semakin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Семакин Алексей Владимирович – аспирант, кафедра общей врачебной практики и поликлинической терапии, СибГМУ; врач-психиатр, психотерапевт</p><p>634050, Томск, Московский тракт, 2,</p><p>634014, Томск, ул. Алеутская, 4</p></bio><bio xml:lang="en"><p>2, Moscow Trakt, Tomsk, 634050,</p><p>4, Aleutskaya Str., Tomsk, 634014</p></bio><email xlink:type="simple">drsemakinav@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федосенко</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedosenko</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Федосенко Сергей Вячеславович – д-р мед. наук, доцент, профессор кафедры общей врачебной практики и поликлинической терапии</p><p>634050, Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2, Moscow Trakt, Tomsk, 634050</p></bio><email xlink:type="simple">s-fedosenko@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-8099-3870</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малиновский</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Malinovskiy</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малиновский Владислав Александрович – аспирант, кафедра общей врачебной практики и поликлинической терапии</p><p>634050, Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2, Moscow Trakt, Tomsk, 634050</p></bio><email xlink:type="simple">vladislav-9509@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-5619-5473</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Агаева</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Agaeva</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Агаева София Александровна – студентка</p><p>634050, Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2, Moscow Trakt, Tomsk, 634050</p></bio><email xlink:type="simple">agaeva.sofiyaa@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4281-1157</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Старовойтова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Starovoytova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Старовойтова Елена Александровна – д-р мед. наук, доцент, зав. кафедрой общей врачебной практики и поликлинической терапии</p><p>634050, Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2, Moscow Trakt, Tomsk, 634050</p></bio><email xlink:type="simple">starovojtova.ea@ssmu.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9640-2028</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Калюжин</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalyuzhin</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Калюжин Вадим Витальевич – д-р мед. наук, профессор, зав. кафедрой госпитальной терапии с курсом реабилитации, физиотерапии и спортивной медицины</p><p>634050, Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2, Moscow Trakt, Tomsk, 634050</p></bio><email xlink:type="simple">kalyuzhinvv@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Сибирский государственный медицинский университет (СибГМУ);&#13;
Томская клиническая психиатрическая больница (ТКПБ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian State Medical University;&#13;
Tomsk Clinical Psychiatric Hospital (TCPH)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Сибирский государственный медицинский университет (СибГМУ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>24</day><month>01</month><year>2024</year></pub-date><volume>22</volume><issue>4</issue><fpage>188</fpage><lpage>200</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Семакин А.В., Федосенко С.В., Малиновский В.А., Агаева С.А., Старовойтова Е.А., Калюжин В.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Семакин А.В., Федосенко С.В., Малиновский В.А., Агаева С.А., Старовойтова Е.А., Калюжин В.В.</copyright-holder><copyright-holder xml:lang="en">Semakin A.V., Fedosenko S.V., Malinovskiy V.A., Agaeva S.A., Starovoytova E.A., Kalyuzhin V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/5435">https://bulletin.ssmu.ru/jour/article/view/5435</self-uri><abstract><p>Большим бременем для всего человечества явилась пандемия новой коронавирусной инфекции 2019 г. (COVID-19), и в скором времени после ее начала исследователи обратили внимание, что элиминация вируса из организма и реконвалесценция не являются завершением болезни. Многие заболевшие не вернулись к прежнему состоянию здоровья и продолжали испытывать жалобы, отражающие патологию разных органов и систем, не могли работать, а некоторые из них столкнулись с психическими расстройствами.</p><p>Цель обзора заключалась в проведении анализа и обобщении опубликованных данных о качестве жизни и расстройствах психической сферы в постковидном периоде. Используя рекомендации «Предпочтительные элементы отчетности для систематических обзоров и метаанализов» (PRISMA) были обнаружены 7 374 научные работы, из которых анализу подлежали 176 англоязычных и 276 русскоязычных подходящих публикаций. В обзор включили 17 (в том числе 2 русскоязычные) статей, соответствующих теме данного обзора. Жалобы на снижение памяти и внимания, появляющиеся не позднее чем через 6 мес после выздоровления от COVID-19 предъявляли 3,2–9,1% пациентов. Астенические симптомы в течение 1-го мес после элиминации нового коронавируса встречались у 55–70% пациентов, а спустя 6 мес – у каждого 5-го.</p><p>При этом поствирусной астенией чаще страдали женщины, выписанные из респираторных госпиталей и лица с хронической бронхолегочной патологией. Нередко выздоровевшие от COVID-19 сталкивались с бессонницей и эмоциональными нарушениями, частота которых также коррелировала с женским полом и тяжелым течением заболевания, потребовавшим госпитализации в отделение реанимации и интенсивной терапии (ОРИТ). В постковидном периоде не исключено развитие депрессивной симптоматики, но достаточных доказательств этому не получено. Качество жизни у этих пациентов заметно снижается, после выписки из стационара часть больных оставалась нетрудоспособна, а у некоторых начались трудности с самообслуживанием. Однако с течением времени имеется тенденция к восстановлению качества жизни, что особенно прослеживается у лиц молодого возраста. У больных, пребывавших в ОРИТ более 7 сут, реабилитационный потенциал гораздо ниже. Психопатологическая симптоматика вносит вклад в снижение качества жизни наряду с физическим компонентом (персистирующее диспноэ, снижение толерантности к физической нагрузке).</p></abstract><trans-abstract xml:lang="en"><p>The 2019 novel coronavirus infection (COVID-19) pandemic has been a great burden for all of humanity. Soon after it began, researchers noticed that elimination of the virus from the body and recovery are not the end of the disease, since many patients did not return to their previous state of health, continued to complain of pathologies of various organs and systems, could not work, and some of them developed mental disorders.</p><p>The aim of the review was to analyze and summarize published data on the quality of life and mental disorders in the post-COVID period. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations, 7,374 scientific works were found, of which 176 English-language and 276 Russianlanguage relevant publications were selected for analysis. The review included 17 (including 2 Russian-language) articles relevant to the topic of this review. Complaints of decreased memory and attention, appearing no later than 6 months after recovery from COVID-19, were reported by 3.2–9.1% of patients. Asthenic symptoms during the first month after the elimination of the novel coronavirus infection occurred in 55–70% of patients, and six months later – in every fifth patient. At the same time, post-viral fatigue more often affected women discharged from respiratory hospitals and persons with chronic bronchopulmonary pathology. Quite often, those who recovered from COVID-19 experienced insomnia and emotional disturbances, the frequency of which also correlated with the female sex and the severe course of the disease, which required hospitalization in the intensive care unit (ICU). In the post-COVID period, the development of depressive symptoms is not excluded, but sufficient evidence for this has not been obtained. The quality of life in these patients decreased. After discharge from the hospital, some patients remained unable to work, and some began to experience difficulties with self-care. However, over time, there is a trend toward restoration of the quality of life, which is especially evident in young people. In patients who have been in the ICU for more than 7 days, the rehabilitation potential is much lower. Psychopathological symptoms contribute to a decrease in the quality of life along with physical factors (persistent dyspnea, decreased exercise tolerance).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>новая коронавирусная инфекция</kwd><kwd>длительный COVID-19</kwd><kwd>постковидный синдром</kwd><kwd>качество жизни</kwd><kwd>тревога</kwd><kwd>депрессия</kwd><kwd>когнитивные нарушения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>novel coronavirus infection</kwd><kwd>prolonged COVID-19</kwd><kwd>post-COVID syndrome</kwd><kwd>quality of life</kwd><kwd>anxiety</kwd><kwd>depression</kwd><kwd>cognitive impairment</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Weekly epidemiological update on COVID-19 - 4 May 2023. Edition 141[Internet]. Geneva: World Health Organization;2023 [cited 2023May4]. URL: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---4-may-2023</mixed-citation><mixed-citation xml:lang="en">Weekly epidemiological update on COVID-19 - 4 May 2023. Edition 141[Internet]. Geneva: World Health Organization;2023 [cited 2023May4]. URL: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---4-may-2023</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Заседание президиума Координационного совета при Правительстве по борьбе с распространением новой коронавирусной инфекции на территории Российской Федерации. М.: Дом Правительства; 2021. URL: http://government.ru/news/43580/</mixed-citation><mixed-citation xml:lang="en">Заседание президиума Координационного совета при Правительстве по борьбе с распространением новой коронавирусной инфекции на территории Российской Федерации. М.: Дом Правительства; 2021. URL: http://government.ru/news/43580/</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Акимкин В.Г., Попова А.Ю., Хафизов К.Ф., Дубоделов Д.В., Углева С.В., Семененко Т.А.и др. COVID-19: эволюция пандемии в России. Сообщение II: динамика циркуляции геновариантов вируса SARS-CoV-2. Журнал микробиологии, эпидемиологии и иммунобиологии. 2022;99(4):381–396. DOI: 10.36233/0372-9311-295.</mixed-citation><mixed-citation xml:lang="en">Акимкин В.Г., Попова А.Ю., Хафизов К.Ф., Дубоделов Д.В., Углева С.В., Семененко Т.А.и др. COVID-19: эволюция пандемии в России. Сообщение II: динамика циркуляции геновариантов вируса SARS-CoV-2. Журнал микробиологии, эпидемиологии и иммунобиологии. 2022;99(4):381–396. DOI: 10.36233/0372-9311-295.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">COVID-19. Временные методические рекомендации. Версия 17. М., 2022:259.</mixed-citation><mixed-citation xml:lang="en">COVID-19. Временные методические рекомендации. Версия 17. М., 2022:259.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. DOI: 10.1136/bmj.n136.</mixed-citation><mixed-citation xml:lang="en">Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. DOI: 10.1136/bmj.n136.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int. J. Clin. Pract. 2021;75(3):e13746. DOI: 10.1111/ijcp.13746.</mixed-citation><mixed-citation xml:lang="en">Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int. J. Clin. Pract. 2021;75(3):e13746. DOI: 10.1111/ijcp.13746.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sher L. Post-COVID syndrome and suicide risk. QJM. 2021;114(2):95–98. DOI: 10.1093/qjmed/hcab007.</mixed-citation><mixed-citation xml:lang="en">Sher L. Post-COVID syndrome and suicide risk. QJM. 2021;114(2):95–98. DOI: 10.1093/qjmed/hcab007.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sadeghipour P., Talasaz A.H., Barco S., Bakhshandeh H., Rashidi F., Rafiee F. et al. Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation onlll. functional outcomes. Eur. J. Intern. Med. 2022;103:76–83. DOI: 10.1016/j.ejim.2022.06.014.</mixed-citation><mixed-citation xml:lang="en">Sadeghipour P., Talasaz A.H., Barco S., Bakhshandeh H., Rashidi F., Rafiee F. et al. Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation onlll. functional outcomes. Eur. J. Intern. Med. 2022;103:76–83. DOI: 10.1016/j.ejim.2022.06.014.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Хабчабов Р.Г., Махмудова Э.Р., Абдуллаев А.А., Гафурова Р.М., Исламова У.А., Джанбулатов М.А. Оценка качества жизни и функционального состояния сердечно-сосудистой системы у пациентов, переболевших COVID-19. Актуальные проблемы медицины. 2021;44(4):373–382.</mixed-citation><mixed-citation xml:lang="en">Хабчабов Р.Г., Махмудова Э.Р., Абдуллаев А.А., Гафурова Р.М., Исламова У.А., Джанбулатов М.А. Оценка качества жизни и функционального состояния сердечно-сосудистой системы у пациентов, переболевших COVID-19. Актуальные проблемы медицины. 2021;44(4):373–382.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2019. URL: http://prisma-statement.org</mixed-citation><mixed-citation xml:lang="en">Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2019. URL: http://prisma-statement.org</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Munblit D., Bobkova P., Spiridonova E., Shikhaleva A., Gamirova A., Blyuss O. et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin. Exp. Allergy. 2021;51(9):1107–1120. DOI: 10.1111/cea.13997.</mixed-citation><mixed-citation xml:lang="en">Munblit D., Bobkova P., Spiridonova E., Shikhaleva A., Gamirova A., Blyuss O. et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin. Exp. Allergy. 2021;51(9):1107–1120. DOI: 10.1111/cea.13997.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mahmud R., Rahman M.M., Rassel M.A., Monayem F.B., Sayeed S.K.J.B., Islam M.S. et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS One. 2021;16(4):e0249644. DOI: 10.1371/journal.pone.0249644.</mixed-citation><mixed-citation xml:lang="en">Mahmud R., Rahman M.M., Rassel M.A., Monayem F.B., Sayeed S.K.J.B., Islam M.S. et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS One. 2021;16(4):e0249644. DOI: 10.1371/journal.pone.0249644.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">COVID-19 rapid guideline: managing the long term effects of COVID-19. Manchester: National Institute for Health and Care Excellence, London: Royal College of General Practitioners, Edinburgh: Healthcare Improvement Scotland SIGN; 2023. URL: www.nice.org.uk/guidance/ng188</mixed-citation><mixed-citation xml:lang="en">COVID-19 rapid guideline: managing the long term effects of COVID-19. Manchester: National Institute for Health and Care Excellence, London: Royal College of General Practitioners, Edinburgh: Healthcare Improvement Scotland SIGN; 2023. URL: www.nice.org.uk/guidance/ng188</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. WHO Clinical Case Definition Working Group on PostCOVID-19 Condition. A clinical case definition of postCOVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22(4):e102–e107. DOI: 10.1016/S1473-3099(21)00703-9.</mixed-citation><mixed-citation xml:lang="en">Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. WHO Clinical Case Definition Working Group on PostCOVID-19 Condition. A clinical case definition of postCOVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22(4):e102–e107. DOI: 10.1016/S1473-3099(21)00703-9.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">International Statistical Classification of Diseases and Related Health Problems 10th Revision. Geneva: World Health Organization; 2019. URL: https://icd.who.int/browse10/2019/en</mixed-citation><mixed-citation xml:lang="en">International Statistical Classification of Diseases and Related Health Problems 10th Revision. Geneva: World Health Organization; 2019. URL: https://icd.who.int/browse10/2019/en</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Jacobs L.G., Gourna Paleoudis E., Lesky-Di Bari D., Nyirenda T., Friedman T., Gupta A. et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15(12):e0243882. DOI: 10.1371/journal.pone.0243882.</mixed-citation><mixed-citation xml:lang="en">Jacobs L.G., Gourna Paleoudis E., Lesky-Di Bari D., Nyirenda T., Friedman T., Gupta A. et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15(12):e0243882. DOI: 10.1371/journal.pone.0243882.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Pérez-González A., Araújo-Ameijeiras A., Fernández-Villar A., Crespo M., Poveda E. Cohort COVID-19 of the Galicia Sur Health Research Institute. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci. Rep. 2022;12(1):3369. DOI: 10.1038/s41598-022-07414-x.</mixed-citation><mixed-citation xml:lang="en">Pérez-González A., Araújo-Ameijeiras A., Fernández-Villar A., Crespo M., Poveda E. Cohort COVID-19 of the Galicia Sur Health Research Institute. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci. Rep. 2022;12(1):3369. DOI: 10.1038/s41598-022-07414-x.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Яхно Н.Н., Захаров В.В., Локшина А.Б., Коберская Н.Н., Мхитарян Э.А. Деменции: руководство для врачей. 4-е изд. М.: МЕДпресс-информ, 2013:264.</mixed-citation><mixed-citation xml:lang="en">Яхно Н.Н., Захаров В.В., Локшина А.Б., Коберская Н.Н., Мхитарян Э.А. Деменции: руководство для врачей. 4-е изд. М.: МЕДпресс-информ, 2013:264.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Захаров В.В. Диагностика и лечение умеренных когнитивных нарушений. Неврология, нейропсихиатрия, психосоматика. 2009;1(2):14–18. DOI: 10.14412/2074-2711-2009-32.</mixed-citation><mixed-citation xml:lang="en">Захаров В.В. Диагностика и лечение умеренных когнитивных нарушений. Неврология, нейропсихиатрия, психосоматика. 2009;1(2):14–18. DOI: 10.14412/2074-2711-2009-32.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Преображенская И.С. Легкие и умеренные когнитивные нарушения: клинические проявления, этиология, патогенез, подходы к лечению. Неврология, нейропсихиатрия, психосоматика. 2013;5(1):59–63. DOI: 10.14412/2074-2711-2013-2401.</mixed-citation><mixed-citation xml:lang="en">Преображенская И.С. Легкие и умеренные когнитивные нарушения: клинические проявления, этиология, патогенез, подходы к лечению. Неврология, нейропсихиатрия, психосоматика. 2013;5(1):59–63. DOI: 10.14412/2074-2711-2013-2401.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Золотовская И.А., Шацкая П.Р., Давыдкин И.Л., Шавловская О.А. Астенический синдром у пациентов, перенесших COVID-19. Журнал неврологии и психиатрии им. С.С. Корсакова. 2021;121(4):25–30. DOI: 10.17116/jnevro202112104125.</mixed-citation><mixed-citation xml:lang="en">Золотовская И.А., Шацкая П.Р., Давыдкин И.Л., Шавловская О.А. Астенический синдром у пациентов, перенесших COVID-19. Журнал неврологии и психиатрии им. С.С. Корсакова. 2021;121(4):25–30. DOI: 10.17116/jnevro202112104125.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Zilberman-Itskovich S., Catalogna M., Sasson E., Elman-Shina K., Hadanny A., Lang E. et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci. Rep. 2022;12(1):11252. DOI: 10.1038/s41598-022-15565-0.</mixed-citation><mixed-citation xml:lang="en">Zilberman-Itskovich S., Catalogna M., Sasson E., Elman-Shina K., Hadanny A., Lang E. et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci. Rep. 2022;12(1):11252. DOI: 10.1038/s41598-022-15565-0.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Жмуров В.А. Психопатология: учебное пособие. Часть II. Иркутск: Издательство Иркутского университета, 1994:217.</mixed-citation><mixed-citation xml:lang="en">Жмуров В.А. Психопатология: учебное пособие. Часть II. Иркутск: Издательство Иркутского университета, 1994:217.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Милевский М.М. Классификации болезней в психиатрии и наркологии: пособие для врачей. М.: Триада-Х, 2003:183.</mixed-citation><mixed-citation xml:lang="en">Милевский М.М. Классификации болезней в психиатрии и наркологии: пособие для врачей. М.: Триада-Х, 2003:183.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu S., Gao Q., Yang L., Yang Y., Xia W., Cai X. et al. Prevalence and risk factors of disability and anxiety in a retrospective cohort of 432 survivors of Coronavirus Disease-2019 (Covid-19) from China. PLoS One. 2020;15(12):e0243883. DOI: 10.1371/journal.pone.0243883.</mixed-citation><mixed-citation xml:lang="en">Zhu S., Gao Q., Yang L., Yang Y., Xia W., Cai X. et al. Prevalence and risk factors of disability and anxiety in a retrospective cohort of 432 survivors of Coronavirus Disease-2019 (Covid-19) from China. PLoS One. 2020;15(12):e0243883. DOI: 10.1371/journal.pone.0243883.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Новик А.А., Ионова Т.И., Кайнд П. Концепция исследования качества жизни в медицине. СПб.: Элби, 1999:140.</mixed-citation><mixed-citation xml:lang="en">Новик А.А., Ионова Т.И., Кайнд П. Концепция исследования качества жизни в медицине. СПб.: Элби, 1999:140.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Pelle A.J., Kupper N., Mols F., de Jonge P. What is the use? Application of the short form (SF) questionnaires for the evaluation of treatment effects. Quality of Life Research. 2013;22(6):1225–1230. DOI: 10.1007/s11136-012-0266-8.</mixed-citation><mixed-citation xml:lang="en">Pelle A.J., Kupper N., Mols F., de Jonge P. What is the use? Application of the short form (SF) questionnaires for the evaluation of treatment effects. Quality of Life Research. 2013;22(6):1225–1230. DOI: 10.1007/s11136-012-0266-8.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., Xia W., Zhan C., Liu S., Yin Z., Wang J. et al. A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial. Thorax. 2022;77(7):697–706. DOI: 10.1136/thoraxjnl-2021-217382.</mixed-citation><mixed-citation xml:lang="en">Li J., Xia W., Zhan C., Liu S., Yin Z., Wang J. et al. A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial. Thorax. 2022;77(7):697–706. DOI: 10.1136/thoraxjnl-2021-217382.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">McNarry M.A., Berg R.M.G., Shelley J., Hudson J., Saynor Z.L., Duckers J. et al. Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur. Respir. J. 2022;60(4):2103101. DOI: 10.1183/13993003.03101-2021.</mixed-citation><mixed-citation xml:lang="en">McNarry M.A., Berg R.M.G., Shelley J., Hudson J., Saynor Z.L., Duckers J. et al. Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur. Respir. J. 2022;60(4):2103101. DOI: 10.1183/13993003.03101-2021.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Dhooria S., Chaudhary S., Sehgal I.S., Agarwal R., Arora S., Garg M. et al. High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial). Eur. Respir. J. 2022;59(2):2102930. DOI: 10.1183/13993003.02930-2021.</mixed-citation><mixed-citation xml:lang="en">Dhooria S., Chaudhary S., Sehgal I.S., Agarwal R., Arora S., Garg M. et al. High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial). Eur. Respir. J. 2022;59(2):2102930. DOI: 10.1183/13993003.02930-2021.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Zasadzka E., Tobis S., Trzmiel T., Marchewka R., Kozak D., Roksela A. et al. Application of an EMG-Rehabilitation Robot in Patients with Post-Coronavirus Fatigue Syndrome (COVID-19)-A Feasibility Study. Int. J. Environ. Res. Public. Health. 2022;19(16):10398. DOI: 10.3390/ijerph191610398.</mixed-citation><mixed-citation xml:lang="en">Zasadzka E., Tobis S., Trzmiel T., Marchewka R., Kozak D., Roksela A. et al. Application of an EMG-Rehabilitation Robot in Patients with Post-Coronavirus Fatigue Syndrome (COVID-19)-A Feasibility Study. Int. J. Environ. Res. Public. Health. 2022;19(16):10398. DOI: 10.3390/ijerph191610398.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Haberland E., Haberland J., Richter S., Schmid M., Hromek J., Zimmermann H. et al. Seven Months after Mild COVID-19: A Single-Centre Controlled Follow-Up Study in the District of Constance (FSC19-KN). Int. J. Clin. Pract. 2022;2022:1–8. DOI: 10.1155/2022/8373697.</mixed-citation><mixed-citation xml:lang="en">Haberland E., Haberland J., Richter S., Schmid M., Hromek J., Zimmermann H. et al. Seven Months after Mild COVID-19: A Single-Centre Controlled Follow-Up Study in the District of Constance (FSC19-KN). Int. J. Clin. Pract. 2022;2022:1–8. DOI: 10.1155/2022/8373697.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Philip K.E.J., Owles H., McVey S., Pagnuco T., Bruce K., Brunjes H. et al. An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial. Lancet Respir. Med. 2022;10(9):851–862. DOI: 10.1016/S2213-2600(22)00125-4.</mixed-citation><mixed-citation xml:lang="en">Philip K.E.J., Owles H., McVey S., Pagnuco T., Bruce K., Brunjes H. et al. An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial. Lancet Respir. Med. 2022;10(9):851–862. DOI: 10.1016/S2213-2600(22)00125-4.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Филиппченкова С.И., Евстифеева Е.А., Мурашова Л.А., Воробьев П.А., Воробьев А.П. Оценка качества жизни, связанного со здоровьем у пациентов с постковидным синдромом. Международный журнал медицины и психологии. 2022;5(5):24–29.</mixed-citation><mixed-citation xml:lang="en">Филиппченкова С.И., Евстифеева Е.А., Мурашова Л.А., Воробьев П.А., Воробьев А.П. Оценка качества жизни, связанного со здоровьем у пациентов с постковидным синдромом. Международный журнал медицины и психологии. 2022;5(5):24–29.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
